An Open-Label Study of CK-3773274 For Patients With Symptomatic Hypertrophic Cardiomyopathy (HCM)
Study of CK-3773274 For Patients With Hypertrophic Cardiomyopathy (HCM)
Sponsor: Cytokinetics, Inc
Enrolling: Male and Female Patients
IRB Number: AAAU5732
U.S. Govt. ID: NCT04848506
Contact: Austin Nguonly, MSc: 212-305-1368 / asn2143@cumc.columbia.edu
Additional Study Information: The purpose of this study is to determine the safety and long-term effects of CK-3773274 and to learn how well it is tolerated at different, increasing dose levels in participants with HCM.
This study is closed
Investigator
Mathew Maurer, MD
Do You Qualify?
Have you completed of a Cytokinetics study investigating CK-3773274? Yes No
Submit
Cancel
You may be eligible for this study

Place Holder



Cancel
For more information, please contact:
Austin Nguonly, MSc
asn2143@cumc.columbia.edu
212-305-1368
This website uses cookies as well as similar tools and technologies to understand visitors’ experiences. By continuing to use this website, you consent to Columbia University’s usage of cookies and similar technologies, in accordance with the Columbia University Website Cookie Notice.
I AGREE